Avicanna Inc.

AVCN

CA05368K1003

Biotechnology & Medical Research

Market Closed - Toronto Stock Exchange Other stock markets 03:59:06 2023-11-29 pm EST			5-day change	1st Jan Change
0.3500 ^CAD	-4.11%		-10.26%	-14.63%

Nov. 15	Transcript : Avicanna Inc., Q3 2023 Earnings Call, Nov 15, 2023	CI
Nov. 14	Avicanna Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Avicanna Inc.

Transcript : Avicanna Inc., Q3 2023 Earnings Call, Nov 15, 2023	Nov. 15	CI
Avicanna Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Avicanna Brief: Citing Improvements in performance including 46% consolidated gross margins and adjusted EBITDA of ($400k)	Nov. 14	MT
Avicanna Brief: Q3 Record revenue of $6.27 Million, representing an increase of 90% over Q2, and 713% year-over-year	Nov. 14	MT
Avicanna Announces Appointment of Paul Fornazzari to Board of Directors	Nov. 13	CI
Avicanna Providing Update on Launch of MyMedi.ca	Oct. 11	MT
Avicanna Brief: Providing Update on Launch of MyMedi.ca; Says Over 96% of active patients from Medical Cannabis by Shoppers successfully transitioned	Oct. 11	MT
Avicanna Inc. Provides Update on the Successful Launch of MyMedi.ca	Oct. 11	CI
Avicanna on Retirement of Chair Chandra Panchal from the Board of Directors	Sep. 05	MT
Avicanna Inc. Announces Retirement of Chandra Panchal, PhD from the Board of Directors	Sep. 01	CI
Avicanna Reports Higher Q2 Revenue	Aug. 15	MT
Avicanna Brief: Q2 2023 revenue of $3.3 million	Aug. 15	MT
Avicanna Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	Aug. 14	CI
Avicanna Inc. Announces Launch of an All-New Medical Cannabis Care Platform, MyMedi.Ca	Aug. 14	CI
Avicanna Inc. announced that it has received CAD 1.455 million in funding	Aug. 01	CI
Avicanna Closes Medical Cannabis by Shopper's Business Acquisition, Launches New Medical Cannabis Care Platform	Aug. 01	MT
Avicanna Brief: Announcing Closing of Acquisition and Launch of Avicanna's new medical cannabis care platform MyMedi.ca	Aug. 01	MT
Avicanna Inc. completed the acquisition of Medical Cannabis by Shoppers Drug Mart Inc from Shoppers Drug Mart Inc.	Jul. 31	CI
Avicanna Subsidiary Completes Export Of Aureus-Branded Products Into Paraguay	Jul. 17	MT
Avicanna Brief: Subsidiary SMGH Exporting Aureus Branded CBD and CBG Into Paraguay	Jul. 17	MT
Transcript : Avicanna Inc. - Special Call	Jun. 28	CI
Avicanna Loses 10% As Reports 200% Increase In Q2 Revenue From Previous Quarter	Jun. 28	MT
Avicanna Reports 200% Increase In Q2 Revenue From Previous Quarter	Jun. 28	MT
Avicanna Brief: Provided Corporate Update and Preliminary Q2 Results	Jun. 28	MT
Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement For Avicanna's SEDDS Technology Capsules	Jun. 26	MT

Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis & Wellness Products (RHO Phyto), Pharmaceutical Pipeline and Medical Cannabis Care Platform (MyMedi.ca). RHO Phyto formulary offers a diverse range of proprietary formulations, including oral, sublingual, topical and transdermal delivery. It has developed a pipeline of patent-pending drug candidates that are indication specific and in various stages of clinical development and commercialization. These cannabinoid-based drug candidates look to address unmet medical needs in the areas of dermatology, chronic pain and various neurological disorders. Its first pharmaceutical preparation (Trunerox) is in the drug registration stage in South America. MyMedi.ca is a medical cannabis care platform that serves medical cannabis patientsâ needs and enhances the patient's journey.

Sector

Biotechnology & Medical Research

Calendar

2024-03-28 - Q4 2023 Earnings Release (Projected)

More about the company

	1st Jan change	Capi. (M$)
AVICANNA INC.	-14.63%	23 M $
SEAGEN INC.	+66.15%	40 283 M $
IQVIA HOLDINGS INC.	+4.35%	39 020 M $
MODERNA, INC.	-56.01%	30 125 M $
LONZA GROUP AG	-24.56%	28 999 M $
ICON PUBLIC LIMITED COMPANY	+37.45%	21 980 M $
ALNYLAM PHARMACEUTICALS, INC.	-30.99%	20 582 M $
CELLTRION, INC.	+0.75%	17 372 M $
UNITED THERAPEUTICS CORPORATION	-16.55%	10 906 M $
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-9.55%	10 111 M $